[go: up one dir, main page]

CR6423A - - Google Patents

Info

Publication number
CR6423A
CR6423A CR6423A CR6423A CR6423A CR 6423 A CR6423 A CR 6423A CR 6423 A CR6423 A CR 6423A CR 6423 A CR6423 A CR 6423A CR 6423 A CR6423 A CR 6423A
Authority
CR
Costa Rica
Application number
CR6423A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR6423A publication Critical patent/CR6423A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CR6423A 1999-01-15 2001-07-12 CR6423A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (xx) 1999-01-15 1999-01-15

Publications (1)

Publication Number Publication Date
CR6423A true CR6423A (xx) 2004-03-09

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6423A CR6423A (xx) 1999-01-15 2001-07-12

Country Status (31)

Country Link
US (5) US6590085B1 (xx)
EP (1) EP1147119B1 (xx)
JP (1) JP2002534530A (xx)
CN (1) CN1167707C (xx)
AR (1) AR022235A1 (xx)
AT (1) ATE250074T1 (xx)
AU (1) AU768511B2 (xx)
BG (1) BG105745A (xx)
BR (1) BR0007553A (xx)
CA (1) CA2359986A1 (xx)
CO (1) CO5180591A1 (xx)
CR (1) CR6423A (xx)
CZ (1) CZ20012540A3 (xx)
DE (1) DE60005300T2 (xx)
DK (1) DK1147119T3 (xx)
ES (1) ES2206176T3 (xx)
HK (1) HK1041270A1 (xx)
HR (1) HRP20010529B1 (xx)
HU (1) HUP0105116A3 (xx)
ID (1) ID30351A (xx)
IN (1) IN190975B (xx)
MA (1) MA25342A1 (xx)
MX (1) MXPA01007187A (xx)
MY (1) MY121135A (xx)
NZ (2) NZ512852A (xx)
PA (1) PA8489901A1 (xx)
PT (1) PT1147119E (xx)
SK (1) SK284241B6 (xx)
TR (1) TR200102043T2 (xx)
WO (1) WO2000042054A1 (xx)
YU (1) YU50701A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (xx) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
MXPA05012900A (es) 2003-05-30 2006-02-22 Ranbaxy Lab Ltd Derivados de pirrol sustituidos.
WO2006024926A1 (en) * 2004-09-02 2006-03-09 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
WO2007010499A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
EP1842855A3 (en) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
EP1864992A2 (en) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (xx) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
PT1147119E (pt) 2004-02-27
SK284241B6 (en) 2004-11-03
CZ20012540A3 (cs) 2002-02-13
YU50701A (sh) 2005-06-10
BR0007553A (pt) 2001-12-18
HRP20010529B1 (en) 2005-02-28
DK1147119T3 (da) 2004-01-19
IN190975B (xx) 2003-09-06
SK10132001A3 (sk) 2002-01-07
DE60005300T2 (de) 2004-07-15
CO5180591A1 (es) 2002-07-30
HRP20010529A2 (en) 2002-08-31
DE60005300D1 (de) 2003-10-23
AR022235A1 (es) 2002-09-04
CN1167707C (zh) 2004-09-22
ID30351A (id) 2001-11-22
AU768511B2 (en) 2003-12-18
EP1147119B1 (en) 2003-09-17
PA8489901A1 (es) 2000-09-29
US20040019191A1 (en) 2004-01-29
JP2002534530A (ja) 2002-10-15
ES2206176T3 (es) 2004-05-16
TR200102043T2 (tr) 2001-11-21
US7005422B2 (en) 2006-02-28
US20040023900A1 (en) 2004-02-05
US20040029820A1 (en) 2004-02-12
WO2000042054A1 (en) 2000-07-20
BG105745A (en) 2002-05-31
HUP0105116A3 (en) 2003-05-28
HK1041270A1 (en) 2002-07-05
CA2359986A1 (en) 2000-07-20
CN1343213A (zh) 2002-04-03
HUP0105116A2 (hu) 2003-04-28
EP1147119A1 (en) 2001-10-24
NZ512852A (en) 2004-02-27
MXPA01007187A (es) 2002-04-24
AU1886100A (en) 2000-08-01
US20040018995A1 (en) 2004-01-29
US7037899B2 (en) 2006-05-02
MY121135A (en) 2005-12-30
US6590085B1 (en) 2003-07-08
NZ527483A (en) 2005-02-25
US7005516B2 (en) 2006-02-28
MA25342A1 (fr) 2001-12-31
ATE250074T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
BE2018C020I2 (xx)
BE2015C057I2 (xx)
BE2016C007I2 (xx)
BE2015C018I2 (xx)
BE2014C017I2 (xx)
BE2013C051I2 (xx)
BE2013C020I2 (xx)
BE2013C015I2 (xx)
BE2013C001I2 (xx)
BE2012C036I2 (xx)
BE2011C004I2 (xx)
BE2008C046I2 (xx)
BE1025464I2 (xx)
BE2010C011I2 (xx)
BRPI0017527B8 (xx)
BE2008C047I2 (xx)
BRPI0001672A2 (xx)
BRPI0001542A2 (xx)
BRPI0012675B8 (xx)
BRPI0017522A2 (xx)
BRMU7902607U2 (xx)
CN3097656S (xx)
CN3098433S (xx)
CN3099877S (xx)
AUPP125099A0 (xx)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)